ERBB2 and breast cancer: Successful clinical applications include the treatment of breast cancer with human epidermal growth factor receptor-2 (HER2)-specific trastuzumab and follicular non-Hodgkin’s B-cell lymphoma with CD20-specific rituximab[33].